Mass-producing iPSC-derived cell therapies while maintaining cell quality: an interview with Kevin Alessandri, TreeFrog Therapeutics



https://www.regmednet.com/mass-producing-ipsc-derived-cell-therapies-while-maintaining-cell-quality-an-interview-with-kevin-alessandri-treefrog-therapeutics/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.